School Of Health Cardiovascular Disease ccyo

Diuretiko (Diuretika) ay nagpapataas ng pag-ihi ng katawan, na nagreresulta sa pagbaba ng presyon ng dugo. Simpleng paliwanag: Ang tuloy-tuloy na pag-ihi ng katawan ay nagdudulot ng pagbaba ng dami ng plasma sa dugo at sa gayon ay mas kaunting likido sa mga ugat — bumababa ang presyon sa mga pader ng ugat. A sedentary lifestyle, alcohol, and cigarette consumption increase body weight which in turn hinders healthy blood circulation and strength of arteries and veins. This results in high blood pressure. So, if you’re overweight, you need to monitor your blood pressure frequently.

School as a starting point for the prevention of cardiovascular diseases Cardiovascular disease (CVD) is the leading cause of death and are associated with significant socio-economic costs. The WHO estimates that annually, approximately 17.9 million people die from the consequences of CVD, which corresponds to 31% of all deaths worldwide. Early prevention is therefore of Central importance. The school offers an ideal starting point, as they reached a large number of children and young people and health-enhancing behaviors can convey in a formative life. Risk factors in childhood and adolescence Many risk factors for CVD are already developing in childhood and adolescence: Lack of exercise: According to studies, many school children are not sufficiently physically active. The WHO recommendation of at least 60 minutes of moderate to intense physical activity is not a day observed by the majority of young people. Unhealthy diet: The high consumption of sugary drinks, processed foods and Snacks leads to an excessive intake of salt, sugar and saturated fatty acids. Overweight and obesity: The prevalence of Overweight and obesity in children is increasing in many countries. Obesity in childhood increases the risk for hypertension, dyslipidemia, and insulin resistance — all precursor of CVD. Tobacco use: Although the onset of Smoking often occurs in adolescence, can prevent the school through education and prevention programs to the early consumption. Measures in school An integrated health promotion in schools can address these risk factors, specifically: Physical education (KE): A sufficient supply of KE-hours and the creation of Movement during and after the class, can increase physical activity. Sports competitions, Walking AGs or break activities are effective approaches. Healthy eating on school location: The provision of healthy meal plans in the school canteen, the absence of sugary drinks in the offer of sale, and the introduction of fruit and vegetable programs promote a balanced diet. Health education in the classroom: issues related to heart health, nutrition, exercise, and stress management should be in the curriculum represented. Interactive modules, and projects to increase the interest and the sustainability of the Learned. School environment as a health-promoting environment: schools can ban Smoking, the creation of sport surfaces, and the promotion of Cycling or driving to school, a health-friendly framework. Working with parents: parents ' involvement in health initiatives (for example, through information, events or sports events) enhances the effect of school-based measures. Conclusion The school's disease is a key site for the early prevention of cardiovascular. Through a combined strategy of increased physical activity, a healthy diet, targeted health education and the creation of a health-promoting school environment, sustainable behavior changes in children and adolescents can be achieved. These measures will not only contribute to the reduction of individual risk, but also promise long-term total social cost-savings due to a reduction in the CVD incidence.

Nililinis ang mga ugat na kailangang alagaan mula sa deposito at pinananatili ang kinakailangang lakas ng tibok ng puso! Ang arteryal na hypertension o hypertension ay isang kondisyon ng patuloy na systolic at diastolic na presyon ng dugo, kung saan ang mga sukatan ay lumalagpas sa 140/90 mmHg. Ang mataas na presyon ay nagpapakita ng mga hindi komportableng sintomas.

Nililinis ang mga ugat na kailangang alagaan mula sa deposito at pinananatili ang kinakailangang lakas ng tibok ng puso!
School Of Health Cardiovascular Disease

Kung nagsimula na ang pag-inom ng gamot para sa mataas na presyon, hindi ibig sabihin na hindi na maaaring gawin ang karagdagang mga hakbang para palakasin ang katawan sa programa ng therapy. Ang benepisyo ng maingat na mga hakbang na pinagkasunduan ng doktor ay nakakatulong para mapigilan ang paglala ng sakit at maiwasang lumipat ito sa mas seryosong yugto.

Punan ang form ng konsultasyon at order School Of Health Cardiovascular Disease. Lilinawin ng operator ang lahat ng detalye sa iyo at ipapadala namin ang iyong order.

School Of Health Cardiovascular Disease. Evalar of hypertension.

Monoclonal antibodies against high blood pressure: A new approach in the therapy High blood pressure, or hypertension, is one of the most common cardiovascular disease worldwide and is recognized as a major risk factor for heart attacks, strokes and kidney disease. Despite a variety of available medications, the effective control of blood pressure remains at a part of patients is a challenge. In recent years, monoclonal antibodies have proved to be promising new therapeutic promise proven approach. Basics of monoclonal antibodies Monoclonal antibodies (mAb; engl. monoclonal antibodies) are artificially produced proteins that bind specifically to certain antigens. Their use in medicine has proven itself in particular in Oncology and autoimmune therapy. The high specificity makes it possible to selectively influence the molecular mechanisms involved in the pathogenesis of diseases. Mechanisms of blood pressure regulation and potential target structures Blood pressure regulation is carried out via a complex neuro-humoral systems, including: the Renin‑Angiotensin‑aldosterone‑System (RAAS), Sympathetic nervous system activity, and the Regulation of sodium ausschie extension by peptides such as natriuretic peptides. One of the most promising starting points for monoclonal antibody inhibition of Angiotensin‑converting sketching that is emitted enzyme 2 (ACE2), or the Modulation of Endothelin‑1, a strong vasoconstrictor is. Other possible targets are: PCSK9 (Proprotein‑Convertase Subtilisin/Kexin type 9), which may also have an influence on blood pressure parameters, Interleukin‑6 (IL‑6) and other proinflammatory cytokines that are involved in vascular dysfunction. Previous Research Results In preclinical studies, monoclonal antibodies, directed against Endothelin‑1 were able to demonstrate a significant reduction in blood pressure in hypertensive animal models. A Phase II study with an Anti‑IL‑6 Receptor antibody demonstrated in patients with rheumatoid Arthritis and concomitant hypertension, a moderate but significant reduction in systolic blood pressure by an average of 8-12 mmHg. Another promising agent is an antibody against Angiotensin II, which blocks binding to the AT1 Receptor. In comparison to classical AT1‑Receptor‑blockers (ARB) provides this approach, a longer duration of action and may be a lower Rate of side effects. Challenges and perspectives Despite the promising results, challenges still exist: high production costs compared to conventional blood pressure potential immunological reactions against foreign proteins, the need for long-term studies on efficacy and safety. However, monoclonal antibodies are opening up new opportunities, particularly for patients with resistant hypertension or comorbid disorders such as chronic renal insufficiency or Diabetes mellitus. Conclusion Monoclonal antibodies represent an innovative approach for the treatment of high blood pressure. Due to their high specificity and long-lasting effect, you could play in the future an important role in the individualized therapy of hypertension. Further clinical studies are required to assess their full potential, and your safety. Would you like me to make a certain section in more detail, or to add further Details to one aspect?